Novozymes A/S
OTC:NVZMF

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
OTC:NVZMF
Watchlist
Price: 62.47 USD 0% Market Closed
Market Cap: 25.7B USD

Wall Street
Price Targets

NVZMF Price Targets Summary
Novozymes A/S

Wall Street analysts forecast NVZMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVZMF is 75.64 USD with a low forecast of 60.05 USD and a high forecast of 92 USD.

Lowest
Price Target
60.05 USD
4% Downside
Average
Price Target
75.64 USD
21% Upside
Highest
Price Target
92 USD
47% Upside
Novozymes A/S Competitors:
Price Targets
IOSP
Innospec Inc
32% Upside
SXT
Sensient Technologies Corp
32% Upside
SY1
Symrise AG
42% Upside
1COV
Covestro AG
4% Upside
WCH
Wacker Chemie AG
1% Upside
EMN
Eastman Chemical Co
17% Upside

Revenue
Forecast

Revenue Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

3%
Past Growth
-55%
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Novozymes A/S

Operating Income forecast
is not available for
Novozymes A/S

Net Income
Forecast

Net Income Estimate
Novozymes A/S

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

0%
Past Growth
-56%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVZMF's stock price target?
Price Target
75.64 USD

According to Wall Street analysts, the average 1-year price target for NVZMF is 75.64 USD with a low forecast of 60.05 USD and a high forecast of 92 USD.

What is Novozymes A/S's Revenue forecast?
Projected CAGR
-55%

For the last 7 years the compound annual growth rate for Novozymes A/S's revenue is 3%. The projected CAGR for the next 2 years is -55%.

What is Novozymes A/S's Net Income forecast?
Projected CAGR
-56%

For the last 7 years the compound annual growth rate for Novozymes A/S's net income is 0%. The projected CAGR for the next 2 years is -56%.

Back to Top